Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma

NCT03896113 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Endometrium Cancer

Interventions

DRUG: Celecoxib 200mg capsule

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain